𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone

✍ Scribed by Rabahi, N.; Chrétien, Y.; Gaouar, F.; Wendum, D.; Serfaty, L.; Chazouillères, O.; Corpechot, C.; Poupon, R.


Book ID
113635052
Publisher
Masson Editeur
Year
2010
Tongue
French
Weight
201 KB
Volume
34
Category
Article
ISSN
0399-8320

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Oral budesonide in the treatment of pati
✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid